World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
23512
World Ranking
1131
National Ranking
39

Medicine

D-Index
89
Citations
23520
World Ranking
12851
National Ranking
400

Daniel Olive publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniel Olive sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 507 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniel Olive D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel Olive sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniel Olive is affiliated with Aix-Marseille University in France and has an extensive record of research publications primarily in medicine and immunology. Their work focuses on subfields including immunology, oncology, molecular biology, infectious diseases, and pulmonary and respiratory medicine.

Their research covers multiple main topics such as immune cell function and interaction, cancer immunotherapy and biomarkers, CAR-T cell therapy research, immunotherapy and immune responses, T-cell and B-cell immunology, immune cells in cancer, and cutaneous lymphoproliferative disorders research.

Recent publications by Daniel Olive include:

  • Major pathways involved in macrophage polarization in cancer, 2022, Frontiers in Immunology
  • Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis, 2021, The Journal of Infectious Diseases
  • 3D Tumor Models and Their Use for the Testing of Immunotherapies, 2020, Frontiers in Immunology
  • Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing, 2022, Nature Communications
  • Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response, 2021, Science Translational Medicine

Frequent coauthors working with Daniel Olive include Laurent Gorvel, Anne-Sophie Chrétien, Aude De Gassart, Norbert Vey, and Stéphane Fattori. Collaborative efforts with these researchers have contributed significantly to their body of work.

Daniel Olive commonly publishes in venues such as Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, Frontiers in Immunology, Regular and Young Investigator Award Abstracts, bioRxiv (Cold Spring Harbor Laboratory), and Cancer Research.

In addition to journal articles, Daniel Olive has contributed to book publications with Frontiers Media, including a 2024 titled work, Highlights from Marie Skłodowska-Curie Actions Fellows 2021.

Best Publications

  • Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction

    Cyril Fauriat;Sylvaine Just-Landi;Françoise Mallet;Christine Arnoulet

  • Anticuerpos contra PD-1 y anticuerpos contra PD-L1 y usos de los mismos

    Olive Daniel;Serriari Nacer-Eddine;Nunes Jacques;Chiotto Marguerite

  • Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.

    Régis T. Costello;Françoise Mallet;Béatrice Gaugler;Danielle Sainty

  • Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.

    Bruno Chetaille;François Bertucci;Pascal Finetti;Benjamin Esterni

  • PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.

    Asma Beldi-Ferchiou;Marion Lambert;Marion Lambert;Stéphanie Dogniaux;Frédéric Vély

  • Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies

    Sandra Heskamp;Willemijn Hobo;Janneke D.M. Molkenboer-Kuenen;Daniel Olive

  • PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.

    Marguerite Ghiotto;Laurent Gauthier;Nacer Serriari;Sonia Pastor

  • ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

    Julien Faget;Nathalie Bendriss-Vermare;Michael Gobert;Isabelle Durand

  • Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

    Mohamad Mohty;David Jarrossay;Marina Lafage-Pochitaloff;Christine Zandotti

  • The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras.

    J A Nunès;Y Collette;A Truneh;D Olive

  • Role of ICAM-3 in the initial interaction of T lymphocytes and APCs

    María C. Montoya;David Sancho;Grégory Bonello;Yves Collette

  • Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

    Luc Xerri;Bruno Chetaille;Nacer Seriari;Coralie Attias

  • The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity

    Yannis Morel;Alemseged Truneh;Raymond W. Sweet;Daniel Olive

  • Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity

    Christine Pasero;Gwenaëlle Gravis;Mathilde Guerin;Samuel Granjeaud

  • Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

    Gilberto Filaci;Marco Fravega;Simone Negrini;Francesco Procopio

  • Physical and Functional Interaction of Nef with Lck HIV-1 Nef-INDUCED T-CELL SIGNALING DEFECTS

    Y. Collette;H. Dutartre;A. Benziane;F. Ramos-Morales

  • CD molecules 2005: human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Ian Nicholson;Bent Aasted

  • Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

    Christine Pasero;Gwenaëlle Gravis;Samuel Granjeaud;Mathilde Guerin

  • The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/Butyrophilin-3 (BTN3A)-specific antibodies

    Aparna Palakodeti;Andrew Sandstrom;Lakshmi Sundaresan;Christelle Harly

  • Tec kinases: a family with multiple roles in immunity.

    Wen-Chin Yang;Yves Collette;Jacques A Nunès;Daniel Olive

Frequent Co-Authors

Patrice Viens
Patrice Viens Aix-Marseille University
Alessandro Moretta
Alessandro Moretta University of Genoa
Emmanuel Scotet
Emmanuel Scotet University of Nantes
Jean-Louis Mege
Jean-Louis Mege Aix-Marseille University
Norbert Vey
Norbert Vey Aix-Marseille University
Christophe Caux
Christophe Caux Cancer Center of Lyon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare roles, such as nursing specializations, can open diverse career pathways. Many professionals pursue advanced qualifications like the cheapest pmhnp certificate programs to specialize in psychiatric nursing, which often overlaps with immunological health issues.

Nurses with a Doctorate in Nursing Practice (DNP) often see improved salary prospects depending on the state, as outlined in average doctorate in nursing salary reports. This makes online DNP programs a smart investment for those focusing on immunological patient care and research.

Transitioning between nursing specialties is also common. For example, Family Nurse Practitioners (FNPs) can gain an acute care certification for fnp, enabling them to work with patients facing severe immunological conditions, enhancing their clinical expertise.

Accelerated pathways like the accelerated np programs also offer a faster route to becoming nurse practitioners, allowing those interested in immunology and related medical fields to advance quickly in their careers. These online degrees combine flexibility with rigorous training, supporting diverse learning needs.

Best Scientists Citing Daniel Olive

Trending Scientists

Recently Published Articles